The results of differential expression analysis (Figure 7A, 7B) and correlation analysis (Figure 7C, 7D) showed that S100A9 was closely related to immunostimulatory genes and immunoinhibitory genes, which suggested that S100A9 might play a role in the treatment of GBM with ICIs. This evidence concerns the gene S100A9 and glioblastoma.